Franklin Resources Inc. Has $1.89 Million Position in Revvity, Inc. (NYSE:RVTY)

Franklin Resources Inc. trimmed its position in Revvity, Inc. (NYSE:RVTY) by 4.6% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 16,969 shares of the company’s stock after selling 812 shares during the quarter. Franklin Resources Inc.’s holdings in Revvity were worth $1,894,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in RVTY. Wealth Enhancement Advisory Services LLC increased its stake in shares of Revvity by 2.4% in the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 4,214 shares of the company’s stock valued at $470,000 after purchasing an additional 100 shares during the last quarter. HB Wealth Management LLC grew its position in Revvity by 4.6% in the fourth quarter. HB Wealth Management LLC now owns 2,380 shares of the company’s stock valued at $266,000 after acquiring an additional 104 shares during the last quarter. Signaturefd LLC raised its stake in Revvity by 6.8% during the fourth quarter. Signaturefd LLC now owns 1,668 shares of the company’s stock worth $186,000 after acquiring an additional 106 shares in the last quarter. Westside Investment Management Inc. lifted its holdings in shares of Revvity by 0.8% in the fourth quarter. Westside Investment Management Inc. now owns 14,363 shares of the company’s stock worth $1,603,000 after acquiring an additional 108 shares during the last quarter. Finally, Coldstream Capital Management Inc. grew its holdings in shares of Revvity by 5.1% during the 3rd quarter. Coldstream Capital Management Inc. now owns 2,247 shares of the company’s stock valued at $286,000 after purchasing an additional 110 shares during the last quarter. 86.65% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, insider Joel S. Goldberg sold 15,170 shares of the stock in a transaction dated Thursday, January 30th. The shares were sold at an average price of $126.73, for a total transaction of $1,922,494.10. Following the transaction, the insider now owns 33,400 shares of the company’s stock, valued at $4,232,782. This represents a 31.23 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Company insiders own 0.68% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages recently commented on RVTY. Raymond James reissued an “outperform” rating and issued a $145.00 price objective (up previously from $140.00) on shares of Revvity in a research note on Monday, February 3rd. KeyCorp increased their price target on Revvity from $132.00 to $145.00 and gave the company an “overweight” rating in a research note on Monday, February 3rd. Barclays lowered their target price on Revvity from $140.00 to $110.00 and set an “overweight” rating for the company in a report on Thursday. Finally, Sanford C. Bernstein lowered Revvity from an “outperform” rating to a “market perform” rating and set a $130.00 price target on the stock. in a research note on Friday, January 10th. Four analysts have rated the stock with a hold rating, eight have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $133.75.

Revvity Trading Up 1.8 %

NYSE:RVTY opened at $94.69 on Monday. Revvity, Inc. has a 52 week low of $89.61 and a 52 week high of $129.50. The company has a debt-to-equity ratio of 0.41, a quick ratio of 3.03 and a current ratio of 3.60. The firm’s fifty day moving average is $109.12 and its 200-day moving average is $115.09. The firm has a market cap of $11.38 billion, a P/E ratio of 42.84, a P/E/G ratio of 3.82 and a beta of 1.07.

Revvity (NYSE:RVTY) last issued its quarterly earnings results on Friday, January 31st. The company reported $1.42 earnings per share for the quarter, topping analysts’ consensus estimates of $1.37 by $0.05. Revvity had a return on equity of 7.68% and a net margin of 9.81%. During the same quarter in the prior year, the company posted $1.25 earnings per share. Equities analysts expect that Revvity, Inc. will post 4.94 earnings per share for the current year.

Revvity Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, May 9th. Shareholders of record on Friday, April 18th will be paid a $0.07 dividend. This represents a $0.28 annualized dividend and a yield of 0.30%. The ex-dividend date is Thursday, April 17th. Revvity’s dividend payout ratio (DPR) is presently 12.67%.

About Revvity

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.